Skip to main content
S&P 5007,551.81-0.45%DOW51,461.90-1.21%NASDAQ25,978.42-0.01%BTC$76,346.00+0.85%ETH$2,420.07+0.87%GOLD$4,327.00-1.38%OIL$101.32-1.08%
Smart Investors Daily
GM

NASDAQ · GMVD

G Medical Innovations Holdings Ltd

Healthcare · Medical - Instruments & Supplies

$0.18

Up+$0.00 (+1.38%)

Updated Sep 17, 2026, 9:19 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.8M
P/E ratio
0
Dividend yield
0.00%
52-week range
— – —
Volume
2.25M
Avg. volume
1.29M

Price performance

GMVD price history

1M range · 0 trading sessions · Daily adjusted prices

GMVD does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest GMVD news

The latest Smart Investors Daily articles mentioning GMVD.

Stock researchCompany · Overview

GMVD research

Overview

Company profile and research snapshot.

Company profile

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
GMVD recent ratings
DateFirmRatingTarget
Jun 20, 2023ThinkEquityBuy—
Jan 18, 2022EF HuttonBuy—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Aug 17, 2023

G Medical Innovations Will Provide Services to Veterans and Military Personnel by Partnering With Resilient Support Services

Rehovot, Israel, Aug. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations”), an industry innovator in comprehensive remote patient monitoring solutions, today announced that its wholly-owned subsidiary, G Medical Innovations USA, Inc., has entered into an agreement with Resilient Support Services Inc. (“RSS”) to expand the health care and remote patient monitoring capabilities to U.S. veterans and military personnel. RSS is a Service-Disabled Veteran-Owned Business that partners with U.S. federal agencies and private sector businesses that are concerned with improving the medical care of veterans and the military community.

GlobeNewswire Inc. · Aug 7, 2023

G Medical Innovations’ CEO Issues Update to Shareholders, August 2023

Rehovot, Israel, Aug. 07, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations” or the “Company”), a global leader in next-generation mobile health (mHealth) and digital health, today issued the following update to shareholders from President and CEO Dr. Yacov Geva.

Benzinga · Aug 4, 2023

Top 5 Health Care Stocks That Could Blast Off In August

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. BIOLASE, Inc. (NASDAQ: BIOL) Biolase reported ...

GlobeNewswire Inc. · May 15, 2023

G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Hearings Panel’s Decision to Grant Exception for Continued Listing

Rehovot, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”) announced today that, on May 11, 2023, the Company received notice from the Hearings Panel (the “Panel”) of the Nasdaq Stock Market LLC (“Nasdaq”) that the Panel has granted the request of the Company to continue its listing on Nasdaq, subject to the conditions described below.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By